Detalhes bibliográficos
| Resumo: | The high prevalence of chronic kidney disease underscores the failure to provide therapies to effectively halt, prevent, and/or reverse renal fibrosis. Thus, the aim of this study was to evaluate the effect of chronic treatment with chaethomellic acid A (CA) on renal fibrosis associated to 5/6 nephrectomy. Methods: Male Wistar rats were subjected to 5/6 nephrectomy (RMR) or sham-operated (SO). One week after surgery, rats were placed in four experimental groups: RMR: rats without treatment (n=13); RMR+CA: rats treated with CA (n=13); SO: rats without treatment (n=13); SO+CA: rats treated with CA (n=13). CA was intraperitoneally administered in a dose of 0.23 µg/Kg three times a week for six months. Renal samples were scored for the following lesions: glomerulosclerosis, interstitial fibrosis, arteriolosclerosis and interstitial inflammation. Results: Animals from the SO and SO+CA groups presented no kidney histological changes. Glomerulosclerosis, interstitial fibrosis and arteriolosclerosis scores were significantly lower (p< 0.001) in RMR+CA group when compared with RMR group. There were no significantly differences in interstitial inflammation score between RMR+CA and RMR groups. Conclusions: This preliminary data suggests that pharmacological inhibition of Ras (small GTPase proteins) activation may be a future strategy in the prevention of renal fibrosis. |
|---|
| Autores principais: | Nogueira, António José M. |
|---|
| Outros Autores: | Vala, Helena; Nóbrega, Carmen; Pires, Carlos André; Colaço, Bruno Jorge; Oliveira, Paula A.; Pires, Maria João |
|---|
| Assunto: | Chaethomellic acid A (CA) 5/6 nephrectomy model |
|---|
| Ano: | 2015 |
|---|
| País: | Portugal |
|---|
| Tipo de documento: | comunicação em conferência |
|---|
| Tipo de acesso: | acesso aberto |
|---|
| Instituição associada: | Instituto Politécnico de Bragança |
|---|
| Idioma: | inglês |
|---|
| Origem: | Biblioteca Digital do IPB |
|---|